Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-044977
Date:2021-06-30
Issuer: VYNE THERAPEUTICS INC. (VYNE)
Original Submission Date:

Reporting Person:

HARSCH MUTYA
520 U.S. HIGHWAY 22, SUITE 204
BRIDGEWATER, NJ 08807

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-06-30 F 3,551 d $3.51 105,322 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 represents shares that have been withheld by the issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.
WhaleWisdom Logo

Elevate your investments